Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3288
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06736418 | Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy | ||
| NCT05720988 | Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia | ||
| NCT02044627 | Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 | ||
| NCT04280653 | An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake | ||
| NCT05153434 | A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome | ||
| NCT01521819 | Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration | ||
| NCT06691828 | Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948 | ||
| NCT02501018 | Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) | ||
| NCT05320588 | A Study in Patients With Advanced Cancers | ||
| NCT03496467 | Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract | ||
| NCT03326674 | Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC | ||
| NCT03655223 | Early Check: Expanded Screening in Newborns | ||
| NCT02260180 | Study of A-101 for the Treatment of Seborrheic Keratosis | ||
| NCT07034768 | A Study to Evaluate EDG-7500 in People With Renal Impairment | ||
| NCT06615479 | A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) | ||
| NCT02685462 | Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin | ||
| NCT02229929 | Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus | ||
| NCT00300053 | ACT34-CMI -- Adult Autologous CD34+ Cells | ||
| NCT03363945 | Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants | ||
| NCT07170644 | A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) | ||
| NCT00413075 | Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | ||
| NCT01819272 | Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks | ||
| NCT06395519 | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies | ||
| NCT03508011 | A Study of IMP4297 in Patients With Advanced Solid Tumors | ||
| NCT05844592 | First in Human, Single Ascending Dose Study | ||
| NCT03576612 | GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas | ||
| NCT06552416 | Safety of MT-401-OTS in Patients With Relapsed AML or MDS | ||
| NCT02449616 | Evaluation of Repeat Administration of Purified Poloxamer 188 | ||
| NCT04395677 | A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene | ||
| NCT00874302 | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms | ||
| NCT01800422 | Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | ||
| NCT04074512 | Copper Histidinate Treatment for Menkes Disease | ||
| NCT04655911 | A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101 | ||
| NCT01831960 | An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris | ||
| NCT03585296 | A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis | ||
| NCT01332188 | Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model | ||
| NCT06841770 | A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury | ||
| NCT00803686 | A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women | ||
| NCT00607373 | Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia | ||
| NCT03191903 | Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide | ||
| NCT02249091 | A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) | ||
| NCT05798897 | Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma | ||
| NCT02375880 | Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder | ||
| NCT03633591 | A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone | ||
| NCT05531890 | Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects | ||
| NCT07035990 | Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. | ||
| NCT05431179 | A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma | ||
| NCT06154070 | An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention | ||
| NCT07197554 | A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies | ||
| NCT06627088 | A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participants |
